OBJECTIVES: Video-assisted thoracoscopic surgery (VATS) lobectomy is quickly becoming the standard of care for many patients with early-stage non-small-cell lung cancer (NSCLC) and benign lung conditions. There is a lack of published data defining the differential impact of preoperative patient comorbidity on outcomes following VATS and OPEN lobectomies, which would be beneficial for procedure selection and clinical decision-making.
INTRODUCTION
Video-assisted thoracoscopic surgery (VATS) lobectomy has rapidly become one of the most important surgical procedures in the treatment of non-small-cell lung cancer (NSCLC) [1] . Numerous studies published over the past 15 years have demonstrated substantial benefits associated with VATS lobectomy, including decreased postoperative pain, faster recovery, lower rates of perioperative pulmonary complications and mortality compared with those of open (OPEN) surgery [2] [3] [4] [5] [6] . In addition, VATS appears to be associated with equivalent oncological outcomes, including lower rates of loco-regional and systemic recurrence [7, 8] . Given the wellestablished relationship between prolonged length of stay and increased costs, there has been widespread interest in identifying drivers of prolonged hospital stay following surgical procedures. While many reports, including several retrospective and prospective studies, have already demonstrated a clear benefit of VATS lobectomy to reduce hospital length of stay, there is a lack of published data defining the differential impact of preoperative patient comorbidities on outcomes following either procedure. The purpose of this study was to compare the preoperative comorbidities of VATS and OPEN lobectomy patients using a large national database and to determine the effect of these comorbidities on postoperative length of stay (PO-LOS).
MATERIALS AND METHODS

Data source
This study is a retrospective cohort analysis of the 2008-2011 Nationwide Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), which is maintained by the Agency for Healthcare Research and Quality (AHRQ). The NIS is the largest database of all-payer inpatient hospital stays in the USA and approximates a 20% stratified sample of all non-federal hospitals. In aggregate, the database contains discrete information from over 8 million inpatient hospital stays annually and in conjunction with provided discharge weights, permits calculation of national estimates representative of all US hospitals. This study was deemed exempt by Yale University's Institutional Review Board.
Inclusion criteria
All adult patients (age ≥18 years) who underwent an OPEN or VATS lobectomy between years 2008 and 2011 were included in the analysis. Procedure type was defined by the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes for OPEN (32.49) or VATS (32.41) lobectomy in any procedure position. 2008 was selected as the first year of the study due to the lack of available ICD-9-CM coding in previous years differentiating OPEN and VATS cases. Patient records with codes for both OPEN and VATS lobectomies were excluded from this analysis with the goal of eliminating cases converted to OPEN procedures. Patients with a preoperative diagnosis of metastatic cancer, as defined by the International Classification of Diseases, Ninth Revision (ICD-9) codes 196.x-199.x, were also excluded from the study, except for those patients only carrying a diagnosis of secondary malignant neoplasm of intrathoracic lymph nodes (196.1).
Demographics
Patient baseline demographic characteristics included age, gender, elective/non-elective admission, hospital location/teaching status (rural/urban, teaching/non-teaching) and expected primary payer (Medicare/Medicaid/private insurance/self-pay/other). Elixhauser comorbidities were generated from ICD-9-CM diagnosis codes (Supplementary Material) using the HCUP Comorbidity Software [9] . All Elixhauser comorbidities were analysed, except for metastatic cancer, which was eliminated due to the study's exclusion criteria. After Elixhauser comorbidities were tallied, the sum of comorbidities for each patient admission was reclassified as 0, 1, 2 or ≥3 for univariable analysis. Due to the fact that some Elixhauser comorbidities have a greater influence on postoperative outcomes than others (as previously reported), individual comorbidities were retained as unique variables in multivariable analysis [10] .
Outcomes
Outcome variables in this study included postoperative lobectomy length of stay (PO-LOS), in-hospital mortality and specific perioperative complications (Supplementary Material). Length of stay postlobectomy was calculated by subtracting the day of hospitalization in which the lobectomy was performed (HCUP-NIS variable 'PRDAYn') from the total length of hospital stay. In-hospital mortality was defined as the percentage of postoperative lobectomy patients who died before discharge. Relevant perioperative pulmonary complications were defined using International Classification of Diseases, Ninth Revision (ICD-9) codes for respiratory complications (997.3), ventilator-associated pneumonia (997.31), aspiration pneumonia from a procedure (997.39), iatrogenic (postoperative) pneumothorax (512.1), pulmonary embolism (PE) (415.11), acute respiratory distress syndrome (ARDS)/acute postoperative respiratory insufficiency (518.5), empyema with fistula (510.0) and lung abscess (513.0).
Statistical analysis
Baseline demographic and clinical characteristics between the primary study cohorts were compared using a two-group, one-way analysis of variance (ANOVA) for continuous variables and the χ 2 test for categorical variables. Elixhauser comorbidities affecting at least 5% of the study population are listed. Continuous variables with a non-normal distribution, including PO-LOS, are presented with medians for comparison. Estimates and their associated standard errors are generated for each variable using methods appropriate for complex sample surveys, taking into account clustering, case weighting and stratification strategy. In accordance with HCUP guidelines, we defined the threshold for including estimates for publication to be a relative standard error less than 30%. PO-LOS was further modelled using the cumulative incidence method, with hospital discharge and death before discharge entered as competing risks. Statistical differences between curves were assessed using the χ 2 test. Multivariable analysis was conducted using a logistic regression model with the outcome of interest defined as a PO-LOS greater than or equal to 14 days, consistent with a previously published metric for prolonged postlobectomy hospitalization [11] . A complex sample procedure utilizing sampling weights was used, taking into account case clustering at the hospital level as well as variable representation of each hospital throughout the 4-year study period. Consistent with published HCUP guidelines regarding hierarchical modelling, to account for hospital-level variation, we fit a hierarchical logistic regression model with hospital entered as a random effect [12] . Multivariable logistic regression was conducted with and without sample weights, with statistically identical results. To adjust for potential confounders and accurately determine factors independently associated with prolonged length of stay, variables from the univariable analysis were selected a priori for inclusion in the multivariable model, based on clinical experience. Each hospital's annual OPEN or VATS lobectomy volume percentile was also included in the model due to the previously published report by this group demonstrating a significant association between hospital VATS procedure volume and shortened PO-LOS [13] . Starting with a full model, predictors with P > 0.05 were removed stepwise until only significant predictors remained. After a significant overall effect was identified, pairwise comparisons were made from the same model with a Bonferroni adjustment. Patient records with missing length of stay data (n = 1) were excluded from multivariable and cumulative incidence analysis. Records missing other demographic data were excluded from univariable analysis but included in all subsequent multivariable analysis if possible. Statistical analysis was performed using the SPSS 22.0 software (SPSS Inc., Chicago, IL).
RESULTS
Baseline characteristics
The HCUP-NIS database contained records of 123 498 inpatient hospital discharges between 2008 and 2011 that fit the study's inclusion criteria, including 85 977 OPEN and 37 521 VATS lobectomies. The univariable baseline demographic characteristics and comorbidities of these patients are summarized in Table 1 . While only those comorbidities present in >5% of patients are presented, all Elixhauser comorbidities were used in subsequent analyses.
Both cohorts differed significantly (P < 0.05) in terms of average age, gender, elective/non-elective admission, location/teaching status of the hospital and expected primary payer. VATS lobectomy patients were more likely to be older, female and have an elective admission compared with patients undergoing OPEN lobectomy. OPEN lobectomy patients were more likely to have three or greater Elixhauser comorbidities (42.0 vs 35.7%, P < 0.001) including fluid and electrolyte disorders (19.8 vs 13.4%, P < 0.001), uncomplicated diabetes (17.0 vs 15.9%, P = 0.04), deficiency anaemias (13.5 vs 10.1%, P < 0.001), chronic pulmonary disease (49.3 vs 43.3%, P < 0.001), obesity (7.8 vs 6.4%, P = 0.001) and weight loss (4.8 vs 2.7%, P < 0.001). VATS patients were more likely to have a history of hypothyroidism (10.8 vs 9.8%, P = 0.015).
Outcomes Table 2 summarizes the univariable postoperative outcomes and complications of lobectomy patients. Patients undergoing VATS had shorter PO-LOS (median stay 5 vs 7 days, P < 0.001) and lower rates of in-hospital mortality (1.5 vs 2.5%, P < 0.001) compared with patients undergoing OPEN. Prolonged PO-LOS (>14 days) was associated with 12.8% of OPEN and 6.0% of VATS cases. OPEN lobectomy patients were more likely to have respiratory complications, aspiration pneumonia, ARDS, empyema with fistula, lung abscess, haematoma, bleeding, as well as gastrointestinal, infectious and cardiac complications (P < 0.05).
A multivariable logistic regression model for PO-LOS of 14 days or greater is presented in Table 3 (r 2 = 0.195, P < 0.001, c-statistic = 0.767). When controlling for potential confounding variables, significant (P < 0.05) independent predictors of prolonged PO-LOS included male gender, non-elective admission, smaller hospital annual lobectomy volume and OPEN lobectomy (vs VATS). Several Elixhauser comorbidities were also predictors of prolonged hospitalization, including deficiency anaemias, congestive heart failure (CHF), chronic pulmonary disease, coagulopathy, diabetes with chronic complications, drug abuse, fluid and electrolyte disorders, pulmonary circulation disorders and weight loss. Hypertension and obesity were associated with shorter lengths of stay.
When analysed using the cumulative incidence function for competing risks data, the probability of discharge for VATS lobectomy patients (Fig. 1 ) was higher than that for OPEN lobectomy patients (χ 2 = 1336.77, P < 0.001) at all times post-lobectomy. Similarly, when restricted to patients with 3 or more comorbidities, VATS lobectomy patients (Fig. 2) had a shorter PO-LOS than OPEN lobectomy patients (χ 2 = 455.33, P < 0.001) at all time points. Lastly, when stratified into cohorts of 0, 1, 2 or greater than 3 Elixhauser comorbidities (Fig. 3) , VATS patients with 2 or more comorbidities were associated with a 'crossover' PO-LOS curve similar to OPEN patients with 0 comorbidities (χ 2 = 379.50, P < 0.001). Comorbidities affecting >5% of the study population are listed. *P-value based on two-group, one-way ANOVA for continuous variables and χ 2 test for categorical variables (P < 0.05 considered statistically significant).
DISCUSSION
The primary results of this study, specifically the association between VATS lobectomy and shorter length of hospital stay, are in accordance with many previously published investigations [2, 14, 15] . The sub-analysis presented in this study, which demonstrates a higher incidence of perioperative pulmonary complications following OPEN lobectomy, has also been previously reported [4, [16] [17] [18] . This investigation has also identified a benefit of VATS lobectomy to reduce PO-LOS even for patients with significant comorbidity. Furthermore, compared with previous reports, the large nature of this study, encompassing over 120 000 patients, afforded a higher degree of statistical power, enabling the identification of several drivers of prolonged length of stay including baseline patient comorbidities. Although an association between increasing comorbidity and longer length of stay has already been established [19] , this study is the first to embrace an established preoperative comorbidity index to determine the impact of these patient-specific characteristics on lobectomy outcomes. When examining the impact of patient comorbidities on postoperative outcomes such as length of stay, it is beneficial to consider a framework in which these baseline comorbidities influence outcomes primarily through complications. While it is difficult to prove causality, numerous studies have demonstrated a strong association between baseline patient characteristics or comorbidities, and the incidence of perioperative pulmonary complications [20] . In addition, although not explored in this study, previous publications have demonstrated a differential impact of specific complications on OPEN and VATS lobectomy [21] . While many important post-lobectomy complications are captured in PO-LOS: postoperative length of stay; CHF: congestive heart failure. *P-value based on logistic regression model (P < 0.05 considered statistically significant). administrative datasets such as the HCUP-NIS, there are additional complications not in the database by which comorbidities impact outcome variables. The results of our multivariable analysis, which demonstrated increased comorbidity as an independent predictor of prolonged hospital stay (P < 0.001), controlling for several major perioperative pulmonary complications, further corroborate the existence of these non-captured complications. Some of the additional mechanisms in which baseline characteristics lead to complications and impact postoperative outcomes include comorbidities influencing inflammatory and immunological reactions, as well as postoperative functional status and social determinants of discharge [22, 23] . While many clinically significant comorbidities were associated with prolonged length of stay in our multivariable analysis, both preoperative hypertension and obesity resulted in shorter hospital stays. A previous study using the HCUP-NIS database demonstrated similar findings [24] . This protective effect may be the result of a correlation between severity of disease and less frequent coding of comparatively benign conditions. Alternatively and although speculative, the protective effect may also be a result of heightened familiarity with these common comorbidities during the study period. It should also be noted that while a statistically significant difference was found on univariable analysis between the hospital location and teaching status of the two primary study cohorts, VATS and OPEN lobectomies, this difference did not independently influence PO-LOS. Instead, hospital setting likely influenced outcomes indirectly through disease severity, as captured in this study through Elixhauser comorbidities. This investigation is limited by the quality of the primary database in terms of completeness, data accuracy and availability of appropriate predictor variables. Compared with prospectively collected data, studies that rely on retrospective data have specific disadvantages including but not limited to selection biases and insufficient variable availability. Some of these biases are eliminated through the use of a multivariable model; however, the strength of the model is only as good as the quality of associated predictor variables. For example, many important data elements that are crucial to clinical decision-making regarding patient candidacy for OPEN or VATS lobectomy were not available for analysis. This includes preoperative functional status, smoking history, pulmonary function test results, tumour characteristics and staging, knowledge of neoadjuvant therapy, surgeon characteristics and severity of comorbid conditions. Not only would these variables provide greater granularity for defining the relationship between preoperative comorbidities and outcomes, but they would also help identify possible confounding variables responsible for introducing biases into the study. Many of these limitations could be addressed in future studies utilizing clinical registry data with more relevant predictor variables and robust documentation of postoperative complications. In general, when compared with administrative data, clinical registries are associated with more thorough and accurate coding of specific clinical outcomes and complications [25] . However, the HCUP-NIS database is extremely comprehensive and has been well validated for use in this initial study. Lastly, the nature of the database, solely capturing inpatient hospital stays, does preclude the ability to comment on any longer term outcomes including post-discharge recovery time, mortality and readmission rates. Despite these limitations, this study demonstrates that the expected length of stay following OPEN lobectomy is significantly greater than the length of stay expected following a VATS procedure, even for patients with greater comorbidity. Furthermore, the expected postoperative length of stay for an OPEN lobectomy patient is approximately equal to that of a VATS patient with an additional 2-3 comorbidities. While the findings of this study demonstrate a difference in length of stay between VATS and OPEN lobectomy based on comorbidities, this should not dissuade a surgeon from abandoning the thoracoscopic approach, particularly if that approach is both preferred and routine. While there are certainly several comorbid conditions and complications that were not included in this study due to the nature of the dataset, the primary conclusion of this analysis would likely remain unchanged. In general, OPEN lobectomy is associated with longer hospital length of stay and a greater number of perioperative pulmonary complications when compared with VATS lobectomy. The results from a randomized clinical trial, or more likely from a retrospective study using a clinical dataset such as the Society of Thoracic Surgeons (STS) national database, would be beneficial to further explore these conclusions.
